1. 1. Hang A, Brietzke SE. Otitis media: epidemiology and management. Infectious disorders drug targets. 2012;12(4):261-6.
2. McNeil JC, Dunn JJ, Kaplan SL, Vallejo JG. Complications of Otitis Media and Sinusitis Caused by Streptococcus anginosus Group Organisms in Children. Pediatr Infect Dis J. 2020;39(2):108-13.
3. Schilder AG, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP, et al. Otitis media. Nat Rev Dis Primers. 2016;2:16063.
4. Bhutta MF, Monono ME, Johnson WD. Management of infective complications of otitis media in resource-constrained settings. Curr Opin Otolaryngol Head Neck Surg. 2020;28(3):174-81.
5. Giese APJ, Ali S, Isaiah A, Aziz I, Riazuddin S, Ahmed ZM. Genomics of Otitis Media (OM): Molecular Genetics Approaches to Characterize Disease Pathophysiology. Front Genet. 2020;11:313.
6. Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani PP. Otitis media: diagnosis and treatment. American family physician. 2013;88(7):435-40.
7. Morris P. Chronic suppurative otitis media. BMJ clinical evidence. 2012;2012.
8. Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, et al. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. Journal of medical microbiology. 2015;64(10):1103-16.
9. Moradali MF, Ghods S, Rehm BH. Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front Cell Infect Microbiol. 2017;7:39.
10. Mansoor T, Musani MA, Khalid G, Kamal M. Pseudomonas aeruginosa in chronic suppurative otitis media: sensitivity spectrum against various antibiotics in Karachi. Journal of Ayub Medical College, Abbottabad : JAMC. 2009;21(2):120-3.
11. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177-92.
12. Song J-J, Lee BD, Lee KH, Lee JD, Park YJ, Park MK. Changes in Antibiotic Resistance in Recurrent Pseudomonas Aeruginosa Infections of Chronic Suppurative Otitis Media. Ear, Nose and Throat Journal. 2020;95(10-11):446-51.
13. McGowan JE, Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med. 2006;119(6 Suppl 1):S29-36; discussion S62-70.
14. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34(5):634-40.
15. Kung VL, Ozer EA, Hauser AR. The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 2010;74(4):621-41.
16. Haas D. Cost of cell–cell signalling in Pseudomonas aeruginosa: why it can pay to be signal-blind. Nature Reviews Microbiology. 2006;4(7):562-.
17. Severi E, Hood DW, Thomas GH. Sialic acid utilization by bacterial pathogens. Microbiology (Reading). 2007;153(Pt 9):2817-22.
18. Lewis AL, Lewis WG. Host sialoglycans and bacterial sialidases: a mucosal perspective. Cell Microbiol. 2012;14(8):1174-82.
19. Cheesbrough M. District Laboratory Practice in Tropical Countries. 2 P, editor: Cambridge University Press; 2nd edition (April 17, 2006); 2006 2006.
20. Mona S Nour MAK, ElSheshtawy NM. Genetic Identification of Pseudomonas aeruginosa Virulence Genes among Different Isolates. Journal of Microbial and Biochemical Technology. 2015;07(05).
21. Loy AH, Tan AL, Lu PK. Microbiology of chronic suppurative otitis media in Singapore. Singapore medical journal. 2002;43(6):296-9.
22. Gaddey HL, Wright MT, Nelson TN. Otitis Media: Rapid Evidence Review. American family physician. 2019;100(6):350-6.
23. Shyamala R, Reddy PJJoM, Research B. The study of bacteriological agents of chronic suppurative otitis media - Aerobic culture and evaluation. 2017;2:152-62.
24. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406(6799):959-64.
25. Schroeder M, Brooks BD, Brooks AE. The Complex Relationship between Virulence and Antibiotic Resistance. Genes (Basel). 2017;8(1):39.
26. Ellappan K, Belgode Narasimha H, Kumar S. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India. J Glob Antimicrob Resist. 2018;12:37-43.
27. Cosson P, Zulianello L, Join-Lambert O, Faurisson F, Gebbie L, Benghezal M, et al. Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol. 2002;184(11):3027-33.
28. Al-Wrafy F, Brzozowska E, Gorska S, Gamian A. Pathogenic factors of Pseudomonas aeruginosa - the role of biofilm in pathogenicity and as a target for phage therapy. Postepy Hig Med Dosw (Online). 2017;71(0):78-91.
29. Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Inhibition of sialidase activity as a therapeutic approach. Drug Des Devel Ther. 2018;12:3431-7.
30. Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, et al. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. Journal of medical microbiology. 2004;53(Pt 1):73-81.
31. Shehab ZH, Laftah BA, editors. Correlation of nan 1 ( Neuraminidase ) and production of some type III secretion system in clinical isolates of Pseudomonas aeruginosa2018.
32. Nikbin VS, Aslani MM, Sharafi Z, Hashemipour M, Shahcheraghi F, Ebrahimipour GH. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol. 2012;4(3):118-23.
33. Michalska M, Wolf P. Pseudomonas Exotoxin A: optimized by evolution for effective killing. Front Microbiol. 2015;6:963-.
34. Stenqvist M, Anniko M, Pettersson A. Effect of Pseudomonas aeruginosa exotoxin A on inner ear function. Acta oto-laryngologica. 1997;117(1):73-9.
35. Ikeda K, Sakagami M, Morizono T, Juhn SK. Permeability of the round window membrane to middle-sized molecules in purulent otitis media. Archives of otolaryngology--head and neck surgery. 1990;116(1):57-60.
36. Colmer JA, Hamood AN. Molecular analysis of the Pseudomonas aeruginosa regulatory genes ptxR and ptxS. Canadian journal of microbiology. 2001;47(9):820-8.
37. Colmer JA, Hamood AN. Characterization of ptxS, a Pseudomonas aeruginosa gene which interferes with the effect of the exotoxin A positive regulatory gene, ptxR. Mol Gen Genet. 1998;258(3):250-9.
38. Amirmozafari N, Fallah Mehrabadi J, Habibi A. Association of the Exotoxin A and Exoenzyme S with Antimicrobial Resistance in Pseudomonas Aeruginosa Strains. Archives of Iranian medicine. 2016;19(5):353-8.
39. World Health O. Chronic suppurative otitis media : burden of illness and management options. Geneva: World Health Organization; 2004.
40. Gellatly SL, Hancock REW. Pseudomonas aeruginosa : new insights into pathogenesis and host defenses. Pathogens and Disease. 2013;67(3):159-73.
41. Mulcahy LR, Isabella VM, Lewis K. Pseudomonas aeruginosa biofilms in disease. Microb Ecol. 2014;68(1):1-12.
42. Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, et al. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Crit Care Med. 2011;39(9):2113-20.
2. Otitis Media: Epidemiology and Management
3. Complications of Otitis Media and Sinusitis Caused by Streptococcus anginosus Group Organisms in Children
4. Management of infective complications of otitis media in resource-constrained settings
5. Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani PP. Otitis media: diagnosis and treatment. Am Fam Physician. 2013;88(7):435-40.